Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
Objectives The benefits of metered‐dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations. The aim of this systematic review was to compare the response to albuterol delivered through nebu...
- Autores:
-
Payares Salamanca, Laura
Contreras-Arrieta, Sandra
Florez, Victor
Barrios-Sanjuanelo, Alexander
Stand-Niño, Ivan
Rodríguez-Martínez, Carlos E.
- Tipo de recurso:
- https://purl.org/coar/resource_type/c_6501
- Fecha de publicación:
- 2020
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/4464
- Palabra clave:
- Acute asthma
Aerosol therapy
Children
Jet nebulizer
Metered-dose inhaler
- Rights
- License
- Acceso abierto
| id |
UNBOSQUE2_7b2a733162d52910fd675643e4d03a47 |
|---|---|
| oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/4464 |
| network_acronym_str |
UNBOSQUE2 |
| network_name_str |
Repositorio U. El Bosque |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| dc.title.translated.spa.fl_str_mv |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| title |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| spellingShingle |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis Acute asthma Aerosol therapy Children Jet nebulizer Metered-dose inhaler |
| title_short |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| title_full |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| title_fullStr |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| title_full_unstemmed |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| title_sort |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis |
| dc.creator.fl_str_mv |
Payares Salamanca, Laura Contreras-Arrieta, Sandra Florez, Victor Barrios-Sanjuanelo, Alexander Stand-Niño, Ivan Rodríguez-Martínez, Carlos E. |
| dc.contributor.author.none.fl_str_mv |
Payares Salamanca, Laura Contreras-Arrieta, Sandra Florez, Victor Barrios-Sanjuanelo, Alexander Stand-Niño, Ivan Rodríguez-Martínez, Carlos E. |
| dc.subject.keywords.spa.fl_str_mv |
Acute asthma Aerosol therapy Children Jet nebulizer Metered-dose inhaler |
| topic |
Acute asthma Aerosol therapy Children Jet nebulizer Metered-dose inhaler |
| description |
Objectives The benefits of metered‐dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations. The aim of this systematic review was to compare the response to albuterol delivered through nebulization (NEB) with albuterol delivered through MDI+S in pediatric patients with asthma exacerbations. Methods We conducted an electronic search in MEDLINE/PubMed, EMBASE, Ovid, and ClinicalTrials. To be included in the review, a study had to a randomized clinical trial comparing albuterol delivered via NEB versus MDI+S; and had to report the rate of hospital admission (primary outcome), or any of the following secondary outcomes: oxygen arterial saturation, heart rate (HR), respiratory rate (RR), the pulmonary index score (PIS), adverse effects, and need for additional treatment. Results Fifteen studies (n = 2057) met inclusion criteria. No significant differences were found between the two albuterol delivery methods in terms of hospital admission (relative risk, 0.89; 95% confidence interval [CI], 0.55–1.46; I2 = 32%; p = .65). There was a significant reduction in the PIS score (mean difference [MD], −0.63; 95% CI, −0.91 to −0.35; I2 = 0%; p < .00001), and a significantly smaller increase in HR (better; MD −6.47; 95% CI, −11.69 to −1.25; I2 = 0%; p = .02) when albuterol was delivered through MDI+S than when it was delivered through NEB. Conclusions This review, an update of a previously‐published meta‐analysis, showed a significant reduction in the PIS and a significantly smaller increase in HR when albuterol was delivered through MDI+S than when it was delivered through NEB. |
| publishDate |
2020 |
| dc.date.accessioned.none.fl_str_mv |
2020-10-15T23:03:04Z |
| dc.date.available.none.fl_str_mv |
2020-10-15T23:03:04Z |
| dc.date.issued.none.fl_str_mv |
2020 |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.local.none.fl_str_mv |
Artículo de revista |
| dc.type.coar.none.fl_str_mv |
https://purl.org/coar/resource_type/c_6501 |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
https://purl.org/coar/resource_type/c_6501 |
| dc.identifier.issn.none.fl_str_mv |
1099-0496 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12495/4464 |
| dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1002/ppul.25077 |
| dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
| dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
| dc.identifier.repourl.none.fl_str_mv |
repourl:https://repositorio.unbosque.edu.co |
| identifier_str_mv |
1099-0496 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co |
| url |
https://hdl.handle.net/20.500.12495/4464 https://doi.org/10.1002/ppul.25077 |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofseries.spa.fl_str_mv |
Pediatric Pulmonology, 1099-0496, 2020 |
| dc.relation.uri.none.fl_str_mv |
https://onlinelibrary.wiley.com/doi/abs/10.1002/ppul.25077 |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.local.spa.fl_str_mv |
Acceso abierto |
| dc.rights.accessrights.none.fl_str_mv |
https://purl.org/coar/access_right/c_abf2 Acceso abierto |
| dc.rights.creativecommons.none.fl_str_mv |
2020-09-17 |
| rights_invalid_str_mv |
Acceso abierto https://purl.org/coar/access_right/c_abf2 2020-09-17 http://purl.org/coar/access_right/c_abf2 |
| dc.format.mimetype.none.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Wiley-Blackwell |
| dc.publisher.journal.spa.fl_str_mv |
Pediatric Pulmonology Pediatric Pulmonology |
| institution |
Universidad El Bosque |
| bitstream.url.fl_str_mv |
https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/f907f88e-b7d1-49b4-adc8-8cfa86bbe7ff/download https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/5d980917-6348-4388-ac7b-0bb2ffba2cb9/download |
| bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 7210a811635d1799e7c05fee5d259be7 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
| repository.mail.fl_str_mv |
bibliotecas@biteca.com |
| _version_ |
1849967214914961408 |
| spelling |
Payares Salamanca, LauraContreras-Arrieta, SandraFlorez, VictorBarrios-Sanjuanelo, AlexanderStand-Niño, IvanRodríguez-Martínez, Carlos E.2020-10-15T23:03:04Z2020-10-15T23:03:04Z20201099-0496https://hdl.handle.net/20.500.12495/4464https://doi.org/10.1002/ppul.25077instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coapplication/pdfengWiley-BlackwellPediatric PulmonologyPediatric PulmonologyPediatric Pulmonology, 1099-0496, 2020https://onlinelibrary.wiley.com/doi/abs/10.1002/ppul.25077Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysisMetered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysisArtículo de revistahttps://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Acute asthmaAerosol therapyChildrenJet nebulizerMetered-dose inhalerObjectives The benefits of metered‐dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations. The aim of this systematic review was to compare the response to albuterol delivered through nebulization (NEB) with albuterol delivered through MDI+S in pediatric patients with asthma exacerbations. Methods We conducted an electronic search in MEDLINE/PubMed, EMBASE, Ovid, and ClinicalTrials. To be included in the review, a study had to a randomized clinical trial comparing albuterol delivered via NEB versus MDI+S; and had to report the rate of hospital admission (primary outcome), or any of the following secondary outcomes: oxygen arterial saturation, heart rate (HR), respiratory rate (RR), the pulmonary index score (PIS), adverse effects, and need for additional treatment. Results Fifteen studies (n = 2057) met inclusion criteria. No significant differences were found between the two albuterol delivery methods in terms of hospital admission (relative risk, 0.89; 95% confidence interval [CI], 0.55–1.46; I2 = 32%; p = .65). There was a significant reduction in the PIS score (mean difference [MD], −0.63; 95% CI, −0.91 to −0.35; I2 = 0%; p < .00001), and a significantly smaller increase in HR (better; MD −6.47; 95% CI, −11.69 to −1.25; I2 = 0%; p = .02) when albuterol was delivered through MDI+S than when it was delivered through NEB. Conclusions This review, an update of a previously‐published meta‐analysis, showed a significant reduction in the PIS and a significantly smaller increase in HR when albuterol was delivered through MDI+S than when it was delivered through NEB.Acceso abiertohttps://purl.org/coar/access_right/c_abf2Acceso abierto2020-09-17http://purl.org/coar/access_right/c_abf2LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/f907f88e-b7d1-49b4-adc8-8cfa86bbe7ff/download8a4605be74aa9ea9d79846c1fba20a33MD52falseAnonymousREADTHUMBNAILLaura Payares‐Salamanca MD Sandra Contreras‐Arrieta _2020.jpgLaura Payares‐Salamanca MD Sandra Contreras‐Arrieta _2020.jpgimage/jpeg5775https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/5d980917-6348-4388-ac7b-0bb2ffba2cb9/download7210a811635d1799e7c05fee5d259be7MD53falseAnonymousREAD20.500.12495/4464oai:pruebas-update-repositorio-unbosque.cloudbiteca.com:20.500.12495/44642022-05-06T23:05:46.006Zmetadata.onlyhttps://pruebas-update-repositorio-unbosque.cloudbiteca.comRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |
